Monday, March 11, 2019

Less Alzheimer's with better sleep and sleep tips

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two



  • Washington University School of Medicine, by Tamara Bhandari.
  • Sleep Tips by NIH MedlinePlus
  • Current Biology, published by Cell Press
  • AlzForum, Rocking Improves Sleep and Memory in Adults, 25 January 2019.

Sleeplessness has just been shown to accelerate the spread of toxic clumps of Alzheimer's tau. "Our brains need time to recover from the stresses of the day," says Dr. David Holtzman. Learn why. Get these 13 tips to a good night's sleep. 

Researchers at Washington University School of Medicine in St. Louis have shown that sleeplessness accelerates the spread through the brain of toxic clumps of tau - a harbinger of brain damage and decisive step along the path to dementia. 



Sleep Deprivation Increases Tau

Poor sleep has long been linked with Alzheimer's disease, but researchers have understood little about how sleep disruptions drive the disease.

Now, studying mice and people, the research team found that sleep deprivation increases levels of the key Alzheimer's protein tau.

These findings, published online in the journal Science, indicate that lack of sleep alone helps drive the disease, and suggests that good sleep habits may help preserve brain health.

Sleep Affects Tau's Spread

"The interesting thing about this study is that it suggests that real-life factors such as sleep might affect how fast the disease spreads through the brain," said senior author David Holtzman, MD, the Andrew B. and Gretchen P. Jones Professor and head of the Department of Neurology. "We've known that sleep problems and Alzheimer's are associated in part via a different Alzheimer's protein -- amyloid beta -- but this study shows that sleep disruption causes the damaging protein tau to increase rapidly and to spread over time."

Tau is normally found in the brain -- even in healthy people -- but under certain conditions it can clump together into tangles that injure nearby tissue and presage cognitive decline. Recent research at the School of Medicine has shown that tau is high in older people who sleep poorly. But it wasn't clear whether lack of sleep was directly forcing tau levels upward, or if the two were associated in some other way. To find out, Holtzman and colleagues including first authors Jerrah Holth, PhD, a staff scientist, and Sarah Fritschi, PhD, a former postdoctoral scholar in Holtzman's lab, measured tau levels in mice and people with normal and disrupted sleep.

Tau Levels Doubled from Disturbed Rest

Mice are nocturnal creatures. The researchers found that tau levels in the fluid surrounding brain cells were about twice as high at night, when the animals were more awake and active, than during the day, when the mice dozed more frequently. Disturbing the mice's rest during the day caused daytime tau levels to double.

Much the same effect was seen in people. Brendan Lucey, MD, an assistant professor of neurology, obtained cerebrospinal fluid -- which bathes the brain and spinal cord -- from eight people after a normal night of sleep and again after they were kept awake all night. A sleepless night caused tau levels to rise by about 50 percent, the researchers discovered.

Tau from Normal Thinking and Doing

Staying up all night makes people stressed and cranky and likely to sleep in the next chance they get. While it's hard to judge the moods of mice, they, too, rebounded from a sleepless day by sleeping more later. To rule out the possibility that stress or behavioral changes accounted for the changes in tau levels, Fritschi created genetically modified mice that could be kept awake for hours at a time by injecting them with a harmless compound. When the compound wears off, the mice return to their normal sleep-wake cycle -- without any signs of stress or apparent desire for extra sleep.

Using these mice, the researchers found that staying awake for prolonged periods causes tau levels to rise. Altogether, the findings suggest that tau is routinely released during waking hours by the normal business of thinking and doing, and then this release is decreased during sleep allowing tau to be cleared away. Sleep deprivation interrupts this cycle, allowing tau to build up and making it more likely that the protein will start accumulating into harmful tangles.

Tau, Memory & Thinking

In people with Alzheimer's disease, tau tangles tend to emerge in parts of the brain important for memory -- the hippocampus and entorhinal cortex -- and then spread to other brain regions. As tau tangles mushroom and more areas become affected, people increasingly struggle to think clearly.

To study whether the spread of tau tangles is affected by sleep, the researchers seeded the hippocampi of mice with tiny clumps of tau and then kept the animals awake for long periods each day. A separate group of mice also was injected with tau tangles but was allowed to sleep whenever they liked. After four weeks, tau tangles had spread further in the sleep-deprived mice than their rested counterparts. Notably, the new tangles appeared in the same areas of the brain affected in people with Alzheimer's.

The researchers also found that disrupted sleep increased release of synuclein protein, a hallmark of Parkinson's disease. People with Parkinson's -- like those with Alzheimer's -- often have sleep problems.

Enough Slow-Wave Sleep is All You Need

Henrik Zetterberg at the University of Gothenburg, Sweden, has reassuring research suggesting that only complete sleep deprivation budges cerebrospinal fluidbiomarkers. In volunteers who slept four hours per day for five nights in a row, he found no change in the tau biomarkers (Olsson et al., 2018).

The volunteers still obtained a normal amount of deep, slow-wave sleep each night, considered the most protective for the brain. He concluded, “One or a few nights of short sleep does not affect tau concentration.”

Sleep Seems to Delay & Slow Dementia

"Getting a good night's sleep is something we should all try to do," Holtzman said. "Our brains need time to recover from the stresses of the day. We don't know yet whether getting adequate sleep as people age will protect against Alzheimer's disease. But it can't hurt, and this and other data suggest that it may even help delay and slow down the disease process if it has begun."

Tips for Getting a Good Night's Sleep

  1. Stick to a sleep schedule. Go to bed and wake up at the same time each day. As creatures of habit, people have a hard time adjusting to changes in sleep patterns. Sleeping later on weekends won't fully make up for a lack of sleep during the week and will make it harder to wake up early on Monday morning.
  2. Exercise is great, but not too late in the day. Try to exercise at least 30 minutes on most days but not later than 2-3 hours before your bedtime.
  3. Avoid caffeine and nicotine before bed. Coffee, colas, certain teas, and chocolate contain the stimulant caffeine, and its effects can take as long as 8 hours to wear off fully. Therefore, a cup of coffee in the late afternoon can make it hard for you to fall asleep at night. Nicotine is also a stimulant, often causing smokers to sleep only very lightly. In addition, smokers often wake up too early in the morning because of nicotine withdrawal.
  4. Avoid alcoholic drinks before bed. Having a "nightcap" or alcoholic beverage before sleep may help you relax, but heavy use robs you of deep sleep and REM sleep, keeping you in the lighter stages of sleep. Heavy alcohol ingestion also may contribute to breathing impairment at night. You also tend to wake up in the middle of the night when the effects of the alcohol have worn off.
  5. Avoid large meals and beverages late at night. A light snack is okay, but a large meal can cause indigestion that interferes with sleep. Drinking too many fluids at night can cause frequent awakenings to urinate.
  6. If possible, avoid medicines that delay or disrupt your sleep. Some commonly prescribed heart, blood pressure, or asthma medications, as well as some over-the-counter and herbal remedies for coughs, colds, or allergies, can disrupt sleep patterns. If you have trouble sleeping, talk to your healthcare provider or pharmacist to see whether any drugs you're taking might be contributing to your insomnia and ask whether they can be taken at other times during the day or early in the evening.
  7. Don't take naps after 3 p.m. Naps can help make up for lost sleep, but late afternoon naps can make it harder to fall asleep at night.
  8. Relax before bed. Don't overschedule your day so that no time is left for unwinding. A relaxing activity, such as reading or listening to music, should be part of your bedtime ritual.
  9. Take a hot bath before bed. The drop in body temperature after getting out of the bath may help you feel sleepy, and the bath can help you relax and slow down so you're more ready to sleep.
  10. Have a good sleeping environment. Get rid of anything in your bedroom that might distract you from sleep, such as noises, bright lights, an uncomfortable bed, or warm temperatures. You sleep better if the temperature in the room is kept cool. A TV, cell phone, or computer in the bedroom can be a distraction and deprive you of needed sleep. Having a comfortable mattress and pillow can help promote a good night's sleep. Individuals who have insomnia often watch the clock. Turn the clock's face out of view so you don't worry about the time while trying to fall asleep.
  11. Have the right sunlight exposure. Daylight is key to regulating daily sleep patterns. Try to get outside in natural sunlight for at least 30 minutes each day. If possible, wake up with the sun or use bright room lights in the morning. Sleep experts recommend that, if you have problems falling asleep, you should get an hour of exposure to morning sunlight and turn down the lights before bedtime.
  12. Don't lie in bed awake. If you find yourself still awake after staying in bed for more than 30 minutes or if you are starting to feel anxious or worried, get up and do some relaxing activity until you feel sleepy. The anxiety of not being able to sleep can make it harder to fall asleep.
  13. See a health professional if you continue to have trouble sleeping. If you consistently find it difficult to fall or stay asleep and/or feel tired or not well rested during the day despite spending enough time in bed at night, you may have a sleep disorder. Your family healthcare provider or a sleep specialist should be able to help you, and it is important to rule out other health or emotional problems that may be disturbing your sleep.

Rock Yourself to Sleep

Dr. Holtzman wants to investigate enhancing slow-wave sleep in mice, to see if it slows the progression of tau pathology. This type of intervention might also work for people. Two new studies show that rocking leads to better sleep and memory consolidation and lengthens slow-wave slumber.

The two new studies reported in Current Biology, one conducted in young adults and the other in mice, add to evidence for the broad benefits of a rocking motion during sleep. In fact, the studies in people show that rocking not only leads to better sleep, but it also boosts memory consolidation during sleep.

Longer Periods of Deeper Sleep

"Having a good night's sleep means falling asleep rapidly and then staying asleep during the whole night," says Laurence Bayer of the University of Geneva, Switzerland. "Our volunteers--even if they were all good sleepers--fell asleep more rapidly when rocked and had longer periods of deeper sleep associated with fewer arousals during the night. We thus show that rocking is good for sleep."

Bayer and their colleagues had earlier shown that continuous rocking during a 45-minute nap helped people to fall asleep faster and sleep more soundly. In the new study, led by Laurence Bayer and Sophie Schwartz, University of Geneva, Switzerland, they wanted to explore the effects of rocking on sleep and its associated brain waves throughout the night.

Rocking Achieves Deeper, Faster Sleep

The researchers enlisted 18 healthy young adults to undergo sleep monitoring in the lab. The first night was intended to get them used to sleeping there. They then stayed two more nights--one sleeping on a gently rocking bed and the other sleeping on an identical bed that wasn't moving.

The data showed that participants fell asleep faster while rocking. Once asleep, they also spent more time in non-rapid eye movement sleep, slept more deeply, and woke up less.

Memory & Sleep

Next, the researchers wanted to know how that better sleep influenced memory. To assess memory consolidation, participants studied word pairs. The researchers then measured their accuracy in recalling those paired words in an evening session compared to the next morning when they woke up. They found that people did better on the morning test when they were rocked during sleep.

Further studies showed that rocking affects brain oscillations during sleep. They saw that the rocking motion caused an entrainment of specific brain oscillations of non-rapid eye movement sleep (slow oscillations and spindles). As a result, the continuous rocking motion helped to synchronize neural activity in the thalamo-cortical networks of the brain, which play an important role in both sleep and memory consolidation.

Better Sleep for Both People and Animals

The second study in mice by Konstantinos Kompotis and colleagues is the first to explore whether rocking promotes sleep in other species. And, indeed, it did. The researchers, led by Paul Franken, University of Lausanne, Switzerland, used commercial reciprocating shakers to rock the cages of mice as they slept.

While the best rocking frequency for mice was found to be four times faster than in people, the researchers' studies show that rocking reduced the time it took to fall asleep and increased sleep time in mice as it does in humans. However, the mice did not show evidence of sleeping more deeply.

Sleep, Rocking and the Vestibular System

Researchers had suspected that the effects of rocking on sleep were tied to rhythmic stimulation of the vestibular system, the sensory system that contributes to the sense of balance and spatial orientation. To explore this notion in the mouse, the researchers studied animals whose vestibular systems were disrupted by non-functioning otolithic organs, found in their ears. Their studies showed that mice lacking working otolithic organs experienced none of the beneficial effects of rocking during sleep.

Taken together, the two studies "provide new insights into the neurophysiological mechanisms underlying the effects of rocking stimulation on sleep," Bayer and Perrault write. The findings may be relevant for the development of new approaches for treating patients with insomnia and mood disorders, as well as older people, who frequently suffer from poor sleep and memory impairments.

Leading to Better Ways to Cope with Insomnia

The researchers say it will be essential in future work to explore the precise deeper brain structures involved in the effects of rocking on sleep. "Current tools, such as optogenetics, can help us decipher which structures, or even neuronal populations, receive the stimulus from the otolithic organs and transfer it further to the structures of the sleep circuitry," Franken says. "Mapping the network of communication between the two systems will provide with basic understanding, as well as novel clinical targets to cope with sleep disorders, like insomnia."

REFERENCES:
SUPPORT:
  • This work was supported by the BrightFocus Foundation, Deutsche Forschungsgemeinschaft, the National Institutes of Health (NIH), the JPB Foundation, the Tau Consortium, and McDonnell Center for Systems Neuroscience at Washington University School of Medicine in St. Louis.
SOURCES:
  • Washington University School of Medicine, by Tamara Bhandari.
  • Sleep Tips by NIH MedlinePlus
  • Current Biology, published by Cell Press
  • AlzForum, Rocking Improves Sleep and Memory in Adults, 25 January 2019.

Saturday, March 9, 2019

Is sundowning curable?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two

University of Cambridge

Early-evening restlessness and agitation, known as 'sundowning', is common in Alzheimer's. So is fragmented sleep. A major discovery indicates these symptoms are curable. 




People with Alzheimer's often have poor biological rhythms, something that is a burden for both patients and their carers. Periods of sleep become shorter and more fragmented, resulting in periods of wakefulness at night and snoozing during the day. They can also become restless and agitated in the late afternoon and early evening, something known as 'sundowning'.

The fly brain is half a millimeter across and contains approximately 100,000 nerve cells (green). The A-beta peptide forms plaques (red) that are linked to nerve cell death and behavioral abnormalities in the flies. Credit: Dr. Stanislav Ott, Department of Genetics, University of Cambridge
Now, scientists from Cambridge have discovered that in fruit flies with Alzheimer's the biological clock is still ticking but has become uncoupled from the sleep-wake cycle it usually regulates. The findings -- published in Disease Models & Mechanisms -- could help develop more effective ways to improve sleep patterns in people with the disease.

Biological clocks go hand in hand with life, and are found in everything from single celled organisms to fruit flies and humans. They are vital because they allow organisms to synchronise their biology to the day-night changes in their environments.

Until now, however, it has been unclear how Alzheimer's disrupts the biological clock. According to Dr Damian Crowther of Cambridge's Department of Genetics, one of the study's authors: "We wanted to know whether people with Alzheimer's disease have a poor behavioural rhythm because they have a clock that's stopped ticking or they have stopped responding to the clock."

The team worked with fruit flies -- a key species for studying Alzheimer's. Evidence suggests that the A-beta peptide, a protein, is behind at least the initial stages of the disease in humans. This has been replicated in fruit flies by introducing the human gene that produces this peptide.

Taking a group of healthy flies and a group with this feature of Alzheimer's, the researchers studied sleep-wake patterns in the flies, and how well their biological clocks were working.

They measured sleep-wake patterns by fitting a small infrared beam, similar to movement sensors in burglar alarms, to the glass tubes housing the flies. When the flies were awake and moving, they broke the beam and these breaks in the beam were counted and recorded.

To study the flies' biological clocks, the researchers attached the protein luciferase -- an enzyme that emits light -- to one of the proteins that forms part of the biological clock. Levels of the protein rise and fall during the night and day, and the glowing protein provided a way of tracing the flies' internal clock.

"This lets us see the brain glowing brighter at night and less during the day, and that's the biological clock shown as a glowing brain. It's beautiful to be able to study first hand in the same organism the molecular working of the clock and the corresponding behaviours," Dr Crowther said.

They found that healthy flies were active during the day and slept at night, whereas those with Alzheimer's sleep and wake randomly. Crucially, however, the diurnal patterns of the luciferase-tagged protein were the same in both healthy and diseased flies, showing that the biological clock still ticks in flies with Alzheimer's.

"Until now, the prevailing view was that Alzheimer's destroyed the biological clock," said Crowther.

"What we have shown in flies with Alzheimer's is that the clock is still ticking but is being ignored by other parts of the brain and body that govern behaviour. If we can understand this, it could help us develop new therapies to tackle sleep disturbances in people with Alzheimer's."

Dr Simon Ridley, Head of Research at Alzheimer's Research UK, who helped to fund the study, said: "Understanding the biology behind distressing symptoms like sleep problems is important to guide the development of new approaches to manage or treat them. This study sheds more light on the how features of Alzheimer's can affect the molecular mechanisms controlling sleep-wake cycles in flies.

"We hope these results can guide further studies in people to ensure that progress is made for the half a million people in the UK with the disease."


Source:
Journal Reference:
  1. K.-F. Chen, B. Possidente, D. A. Lomas, D. C. Crowther. The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer's disease. Disease Models & Mechanisms, 2014; DOI:10.1242/dmm.014134

Thursday, March 7, 2019

Can you detect Alzheimer's early with a blood test?

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Washington University School of Medicine

A simple experimental blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s – long before they show signs of confusion and memory loss. 




A simple blood test reliably detects signs of brain damage in people on the path to developing Alzheimer’s disease – even before they show signs of confusion and memory loss, according to a new study from Washington University School of Medicine in St. Louis and the German Center for Neurodegenerative Diseases in Germany




The findings, published Jan. 21 in Nature Medicine, may one day be applied to quickly and inexpensively identify brain damage in people with not just Alzheimer’s disease but other neurodegenerative conditions such as multiple sclerosis, traumatic brain injury or stroke.

Screening Test in Neurology Clinic

“This is something that would be easy to incorporate into a screening test in a neurology clinic,” said Brian Gordon, PhD, an assistant professor of radiology at Washington University’s Mallinckrodt Institute of Radiology and an author on the study. “We validated it in people with Alzheimer’s disease because we know their brains undergo lots of neurodegeneration, but this marker isn’t specific for Alzheimer’s. High levels could be a sign of many different neurological diseases and injuries.”

Serum Neurofilament Light Chain (NfL) Levels

The test detects neurofilament light chain, a structural protein that forms part of the internal skeleton of neurons. When brain neurons are damaged or dying, the protein leaks out into the cerebrospinal fluid that bathes the brain and spinal cord and from there, into the bloodstream.

Finding high levels of the protein in a person’s cerebrospinal fluid has been shown to provide strong evidence that some of their brain cells have been damaged. But obtaining cerebrospinal fluid requires a spinal tap, which many people are reluctant to undergo. Senior author Mathias Jucker, PhD, a professor of cellular neurology at the German Center for Neurodegenerative Diseases in Tübingen, along with Gordon and colleagues from all over the world, studied whether levels of the protein in blood also reflect neurological damage.

Testing Families from DIAN

They turned to a group of families with rare genetic variants that cause Alzheimer’s at a young age – typically in a person’s 50s, 40s or even 30s. The families form the study population of The Dominantly Inherited Alzheimer Network (DIAN), an international consortium led by Washington University that is investigating the roots of Alzheimer’s disease. A parent with such a mutation has a 50 percent chance of passing the genetic error to a child, and any child who inherits a variant is all but guaranteed to develop symptoms of dementia near the same age as his or her parent. This timeline gives researchers an opportunity to study what happens in the brain in the years before cognitive symptoms arise.

The researchers studied more than 400 people participating in the DIAN study, 247 who carry an early-onset genetic variant and 162 of their unaffected relatives. Each participant had previously visited a DIAN clinic to give blood, undergo brain scans and complete cognitive tests. Roughly half had been evaluated more than once, typically about two to three years apart.

16 Years Before Alzheimer's

In those with the faulty gene variant, protein levels were higher at baseline and rose over time. In contrast, protein levels were low and largely steady in people with the healthy form of the gene. This difference was detectable 16 years before cognitive symptoms were expected to arise.

In addition, when the researchers took a look at participants’ brain scans, they found that how quickly the protein levels rose tracked with the speed with which the precuneus – a part of the brain involved in memory – thinned and shrank.

“Sixteen years before symptoms arise is really quite early in the disease process, but we were able to see differences even then,” said Washington University graduate student Stephanie Schultz, one of the paper’s co-first authors. “This could be a good preclinical biomarker to identify those who will go on to develop clinical symptoms.”

To find out whether protein blood levels could be used to predict cognitive decline, the researchers collected data on 39 people with disease-causing variants when they returned to the clinic an average of two years after their last visit. The participants underwent brain scans and two cognitive tests: the Mini-Mental State Exam and the Logical Memory test. The researchers found that people whose blood protein levels had previously risen rapidly were most likely to show signs of brain atrophy and diminished cognitive abilities when they revisited the clinic.

Confirming Findings

“It will be important to confirm our findings in late-onset Alzheimer´s disease and to define the time period over which neurofilament changes have to be assessed for optimal clinical predictability,” said Jucker, who leads the DIAN study in Germany.

All kinds of neurological damage can cause the neurofilament light protein to spill out of neurons and into blood. Protein levels are high in people with Lewy body dementia and Huntington’s disease; they rise dramatically in people with multiple sclerosis during a flare-up and in football players immediately after a blow to the head.

Commercial Kits & FDA Approval

A commercial kit – very similar to the one used by the authors – is available to test for protein levels in the blood, but it has not been approved by the FDA to diagnose or predict an individual’s risk of brain damage. Before such a test can be used for individual patients with Alzheimer’s or any other neurodegenerative condition, researchers will need to determine how much protein in the blood is too much, and how quickly protein levels can rise before it becomes a cause for concern.

“I could see this being used in the clinic in a few years to identify signs of brain damage in individual patients,” said Gordon, who is also an assistant professor of psychological & brain sciences. “We’re not at the point we can tell people, ‘In five years you’ll have dementia.’ We are all working towards that.”

REFERENCE:
SOURCE:
  • Washington University School of Medicine
    The School of Medicine is a leader in medical research, teaching and patient care, ranking among the top 10 medical schools in the nation by U.S. News & World Report.
SUPPORT:
  • This study was supported by the Dominantly Inherited Alzheimer Network, grant number UF1AG032438, funded by the National Institute on Aging and the German Center for Neurodegenerative Diseases (DZNE); the National Institute of Neurological Diseases and Stroke Center Core for Brain Imaging, grant number P30NS098577; the National Science Foundation, grant number DGE-1745038; the National Institutes of Health (NIH), grant number UL1TR001873; the Swiss National Science Foundation, grant number 320030-160221; the National Institute for Health Research; University College London Hospitals Biomedical Research Centre; and the MRC Dementias Platform UK, grant numbers MR/L023784/1 and MR/009076/1.

Tuesday, March 5, 2019

Fight dementia by eating chocolate

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two



NutritionFacts.org

Take cocoa's flavanol phytonutrients, leave out the sugar and fat, and you get a health food that improves arterial function. That's a great way to fight strokes and atherosclerosis, common triggers of vascular dementia. See NutritionFacts.org analyze the latest research. 




The problem with publishing research on chocolate is that the press jumps on it, oversimplifying and sensationalizing the message. Then, the money starts rolling in from candy companies, muddying the message. But, lost in all that is an important idea—that the flavanol phytonutrients in cocoa do appear to be beneficial. 


The sugar in chocolate isn’t good for us; the fat and excess calories in chocolate aren’t good for us; but, “natural cocoa powder can be [considered] a health food.” So, adding cocoa to a smoothie, or oatmeal, or whatever, would be health-promoting. But, ideally, choose unprocessed, un-Dutched cocoa, since the flavanols are what give cocoa its bitterness. So, they try to process cocoa with alkali to destroy them, on purpose. Thus, when it comes to cocoa, “bitter [appears to be] better.” 

In my video on chocolate and artery function, I showed how dark chocolate could improve the function of coronary arteries in the heart within two hours of consumption, using fancy angiography. But, there are some blood vessels you can visualize with your eyes—the blood vessels in your eyes. Two hours after eating dark chocolate; significant improvement in the ability of the little veins in your eyes to dilate. 

What about the blood vessels in your legs? Peripheral artery disease—atherosclerosis in the arteries feeding your limbs, leading to claudication, a crampy pain in your calf muscles when you try to exercise, due to impaired blood flow. So, maximal walking distance and maximal walking time were studied in 20 peripheral artery disease patients, two hours after eating dark chocolate, with a respectable 85+% cocoa, or after eating wimpy milk chocolate. After the dark chocolate, they could walk about a dozen more yards, and about 17 more seconds, than before the dark chocolate. 

But, after the milk chocolate they weren’t even able to walk as far as baseline, and not a single second more. So, there does seem to be something in cocoa that’s helping, but a few seconds here or there aren’t going to cut it. 

How about reversing the atherosclerosis—which we didn’t even think possible, until 1977? Wait—what happened in ’77? Dean Ornish didn’t start publishing on heart disease reversal until 1979. Well, actually, the first demonstration of atherosclerosis reversal with a cholesterol-lowering diet and drugs wasn’t on the coronary arteries going to the heart, but rather the femoral arteries, going to the legs. 

What about the arteries going to the brain? Well, there’s a noninvasive way to measure arterial function within the brain, using transcranial ultrasound. If you ask someone to hold their breath, the brain says uh-oh, and starts opening up the arteries to increase blood flow to compensate. But, if the arteries in our brain are stiffened and crippled by atherosclerosis, they’re unable to open as much and as fast as they should—and so, are said to have a smaller “breath holding index,” which can be a risk factor for stroke. So, researchers designed an experiment in which they compared the results of a target food to something neutral, like oatmeal. So, did they choose like a spoonful of cocoa powder, or something? No. A randomized crossover trial of oatmeal, versus a “deep-fried Mars bar.” 

Wait, why a deep-fried Mars bar? Well, this was published in the Scottish Medical Journal, and, evidently, deep-fried Mars bars are “a snack…strongly [associated] with Scotland.” Wait, is this just an urban legend, or something? No. “627 fish and chip shops in Scotland [were called] to ascertain the delicacy’s availability,” and more than one in five said yeah, we’re selling up to 200 a week. Just follow the signs. Comes out a little something like this. Batter-dipped and deep-dried Snickers bars and pizza were, evidently, less popular. The researchers conclude that it’s “not just an urban [legend]. Encouragingly, [they] did find some evidence of the penetrance of the Mediterranean diet…albeit in the form of deep-fried pizza.” 

Could this be contributing to Scotland having among the highest stroke rate in Europe? Well, they put it to the test, and, interestingly, there was a significant drop in men, compared to women. Maybe men are from Mars, women are from Snickers? 

Regardless, what about chocolate that’s not deep-fried? There’s been a few population studies that have followed people over time, and found that those who ate chocolate appeared to have lower stroke rates—since confirmed by another study. 

But, maybe chocolate consumption just happens to be related to other behaviors that are heart- and brain-healthy? Like hey, people that exercise a lot have to eat more food, period. So, maybe they eat more chocolate? They didn’t see any evidence of that, but you can’t account for everything. To prove cause and effect, you’d have to like randomize people into two groups, and make half eat chocolate, and the other half not, and follow them out for a decade or two—to which one researcher replied, fat chance; you try to get people into a study where they could be randomized to 16 years without chocolate. 

Sunday, March 3, 2019

Help older adults stay warm in winter

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two






Older adults can be particularly vulnerable in cold weather. Here are six ways to stay warm & comfortable during the winter months.


  1. Try to stay away from cold places. Changes in the body that come with aging can make it harder for older adults to be aware of getting cold.
  2. Check the weather forecasts for windy and cold weather. Try to stay inside or in a warm place on cold and windy days. If you have to go out, wear warm clothes including a hat and gloves. A waterproof coat can help you stay warm if it's cold and snowy.
  3. Wear several layers of loose clothing when it's cold. The layers will trap warm air between them. Don't wear tight clothing because it can keep your blood from flowing freely. This can lead to loss of body heat.
  4. Ask your doctor how the medicines you are taking affect body heat. Some medicines used by older people can increase the risk of accidental hypothermia. These include drugs used to treat anxiety, depression, or nausea. Some over-the-counter cold remedies can also cause problems.
  5. When the temperature outside has dropped, drink alcohol moderately, if at all. Alcoholic drinks can make you lose body heat.
  6. Make sure you eat enough food to keep up your weight. If you don't eat well, you might have less fat under your skin. Body fat helps you to stay warm.

Friday, March 1, 2019

Why curry for Alzheimer's

Caregivers, and healthcare professionals,here is some great information

Here is a great dementia resource for caregivers and healthcare professionals,

Follow alzheimersideas on twitter

The Dementia Caregiver's Little Book of Hope [Kindle Edition]

Your residents will love the Amazon Kindle Fire

Here is information on being the best caregiver you can be

Here is a way for nurses administrators, social workers and other health care  professionals to get an easyceu or two


Salk researchers

J147 is a derivative of curry's turmeric spice. It beat the Alzheimer's drug Aricept (generic: donepezil) on several memory tests. The Salk Institute says it may benefit Parkinson's, Huntington's & vascular dementia. Find out how J147 prevented memory loss & slowed Alzheimer's. 




LA JOLLA, CA—A drug developed by scientists at the Salk Institute for Biological Studies, known as J147, reverses memory deficits and slows Alzheimer's disease in aged mice following short-term treatment. 

J147 was developed at Salk in the laboratory of David Schubert, a professor in the Cellular Neurobiology Laboratory.

India has Less Alzheimer's than the USA

Dr. Schubert said,
"It's been known for a long time that people in India don't get very much Alzheimer's relative to what happens in the United States and the rest of the world.

"One of the curiousities about the diet in India is that they eat a lot of curry. A major spice in curry is turmeric. A major component of turmeric is curcumin.

"Curcumin has been around for a while. It is an FDA-Approved drug for cancer. A friend of mine in Los Angeles, Greg Cole, found that if you give curcumin to very similar mice to what this study's author has been using, they get a little better, the (Alzheimer's) plaques go away.

"The problem with curcumin is that it is not a great drug, in the sense that it gets degraded very rapidly. It's availability is quite low in the bloodstream and the brain.

"We decided to make a better version of this.We did a lot of medicinal chemistry. We came up with J147."

"Strong Potential to Slow Alzheimer's"

Lead study author Marguerite Prior, a research associate in Salk's Cellular Neurobiology Laboratory, added,
"J147 is an exciting new compound because it really has strong potential to be an Alzheimer's disease therapeutic by slowing disease progression and reversing memory deficits following short-term treatment."
Because of its broad ability to protect nerve cells, the researchers believe that J147 may also be effective for treating other neurological disorders, such as Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis (ALS), as well as vascular dementia from stroke, although their study did not directly explore the drug's efficacy as a therapy for those diseases. 
The findings, published in the journal Alzheimer's Research and Therapy, may pave the way to a new treatment for Alzheimer's disease in humans. 

Despite years of research, scientists are still seeking the first disease-modifying drugs for Alzheimer's. Current FDA-approved medications include

  1. Aricept® (generic donepezil)
  2. Razadyne® (generic galantamine)
  3. Exelon® (generic rivastigmine, sometimes branded as Ebixa® in Europe)
These offer only fleeting short-term benefits for Alzheimer's patients, but they do nothing to slow the steady, irreversible decline of brain function that erases a person's memory and ability to think clearly.

Protecting Brain Cells

Professor Schubert and his colleagues bucked the trend within the pharmaceutical industry, which has focused on the biological pathways involved in the formation of amyloid plaques, the dense deposits of protein that characterize the disease. Instead, the Salk team used living neurons grown in laboratory dishes to test whether their new synthetic compounds, which are based upon natural products derived from plants, were effective at protecting brain cells against several pathologies associated with brain aging. 

From the test results of each chemical iteration of the lead compound, they were able to alter their chemical structures to make them much more potent. Although J147 appears to be safe in mice, the next step will require clinical trials to determine whether the compound will prove safe and effective in humans. Professor Schubert said,

"Alzheimer's disease research has traditionally focused on a single target, the amyloid pathway, but unfortunately drugs that have been developed through this pathway have not been successful in clinical trials. Our approach is based on the pathologies associated with old age - the greatest risk factor for Alzheimer's and other neurodegenerative diseases - rather than only the specificities of the disease."
J147
Salk scientists developed J147, a synthetic drug shown to improve memory and prevent brain damage in mice with Alzheimer's disease.

Images: Courtesy of the Salk Institute for Biological Studies
To test the efficacy of J147 in a much more rigorous preclinical Alzheimer's model, the Salk team treated mice using a therapeutic strategy that they say more accurately reflects the human symptomatic stage of Alzheimer's. Administered in the food of 20-month-old genetically engineered mice, at a stage when Alzheimer's pathology is advanced, J147 rescued severe memory loss, reduced soluble levels of amyloid, and increased neurotrophic factors essential for memory, after only three months of treatment. 

In a different experiment, the scientists tested J147 directly against Aricept (generic donepezil), the most widely prescribed Alzheimer's drug, and found that it performed as well or better in several memory tests. 

"In addition to yielding an exceptionally promising therapeutic, both the strategy of using mice with existing disease and the drug discovery process based upon aging are what make the study interesting and exciting," says Schubert, "because it more closely resembles what happens in humans, who have advanced pathology when diagnosis occurs and treatment begins." Most studies test drugs before pathology is present, which is preventive rather than therapeutic and may be the reason drugs don't transfer from animal studies to humans.

Helps New Neurons Grow & Connect

Prior and her colleagues say that several cellular processes known to be associated with Alzheimer's pathology are affected by J147, including an increase in a protein called brain-derived neurotrophic factor (BDNF), which protects neurons from toxic insults, helps new neurons grow and connect with other brain cells, and is involved in memory formation. Postmortem studies show lower than normal levels of BDNF in the brains of people with Alzheimer's. 

The Salk researchers say that J147, with its memory enhancing and neuroprotective properties, along with its safety and availability as an oral medication, would make an "ideal candidate" for Alzheimer's disease clinical trials. They are currently seeking funding for such a trial. 

MORE INFORMATION:
Other researchers on the study were Richard Dargusch, Jennifer L. Ehren and Chandra Chiruta, of the Salk Institute.

The work was supported by the Alzheimer's Drug Discovery Foundation, the Bundy Foundation, the Fritz Burns Foundation, the George E. Hewitt Foundation, the Alzheimer's Association, and the National Institutes of Health.

About the Salk Institute for Biological Studies:
The Salk Institute for Biological Studies is one of the world's preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.

Faculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, M.D., the Institute is an independent nonprofit organization and architectural landmark

Blog Flux Directory
alzheimersideas - whereIstand.com

Fitness is important in dementia prevention. Click below for more info